Tucker Kelly

Tucker Kelly

Finansdirektör/CFO på XENON PHARMACEUTICALS INC.

Förmögenhet: - $ per 2026-06-30

55 år
Health Technology
Finance
Commercial Services

Profil

Thomas P.
Kelly
is currently Chief Financial Officer at Xenon Pharmaceuticals, Inc. since 2025.
Formerly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. from 2015 to 2019, Chief Financial Officer at AdvanDx, Inc. from 2012 to 2015, Chief Financial Officer at deCODE Genetics ehf from 2010 to 2011, Chief Financial Officer and SVP-Finance & Corporate Development at Critical Therapeutics, Inc. from 2007 to 2008, Principal at Canaccord Adams, Inc. from 2003 to 2007, Vice President-Life Sciences Investment Banking at Robertson Stephens, Inc. from 1998 to 2002, and Associate at Foley Hoag LLP from 1996 to 1998.
Education includes graduate studies at The University of Chicago Law School and undergraduate studies at Edmund A. Walsh School of Foreign Service.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2025-10-15 0 ( -.--% ) - $ 2026-06-30

Aktiva positioner av Tucker Kelly

FöretagPositionStart
XENON PHARMACEUTICALS INC. Finansdirektör/CFO 2025-10-15

Tidigare kända positioner av Tucker Kelly

FöretagPositionSlut
Finansdirektör/CFO 2015-03-16
Finansdirektör/CFO 2011-01-01
Finansdirektör/CFO 2008-11-04
Företagsledare/Principal 2007-08-01
Företagsledare/Principal 2002-07-01
Se detaljerna i Tucker Kellys erfarenhet

Tucker Kellys utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

88

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Finance

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

  1. Börsen
  2. Insiders
  3. Tucker Kelly